Priority Date: 10.02.06 (EP 20060101551)

PIPERIDINE DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS

  • Application ID: EP07726319
  • Status: The application is deemed to be withdrawn

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Janssen Pharmaceutica N.V. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 225 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 10.02.2006 - Priority Date (EP 20060101551)
  • 16.08.2007 - Publication A2 (WO2007090836)
  • 29.10.2008 - Publication A2 (EP1983986)